Transplant Quality Institute - Palm Springs 2019

6th Annual Transplant Quality Institute Conference is organized by American Foundation for Donation and Transplantation (AFDT) and will be held from Oct 02 - 04, 2019 at Omni Rancho Las Palmas Resort & Spa, Palm Springs, California, United States of America.

Who Should Attend?
The scope of this course is focused transplant quality training making it an ideal opportunity for:
• Transplant program leadership with oversight responsibility for quality
• TransplantPhysicians andSurgeons with responsibility for quality in transplant
• Transplant Clinical, Data, and Operational Managers
• Transplant Quality Coordinators/Officers
• Transplant Compliance Coordinators/Officers
• Transplant/Hospital Improvement Engineers/Staff
• Transplant/Hospital Educators with responsibility to educate and engage staff in quality
• Hospital Quality/Patient Safety/Risk Management
• Hospital Administrators and Executives responsible for transplant programs
• Transplant Administrators

Purpose:
In the midst of today’s ever-changing transplant landscape, its allocation systems, and complex regulatory processes, the 6th Annual Transplant Quality Institute remains committed to the founding mission of providing current and relevant education, resources, and tools necessary to remain focused, competitive, and compliant in today’s healthcare market while preserving our tradition of presenting foundational material for professionals new to transplant quality.

Objectives:
• Describe the intent of the SRTR 5-tier system.
• Discuss current and future initiatives of OPTN/UNOS.
• Describe the current state of CMS interpretive guidelines.
• Identify perioperative quality metrics and monitoring techniques for capturing adverse events in the operating rooms.
• Discuss methods for increasing engagement in responding to OPTN public policy proposals.
• Evaluate potential impact of organ allocation based on broader geographic distribution principles.
• Describe results of the ad hoc OPTN Systems Performance Committee.
• Explain the effective use of organ offer tools in decision-making.
• Analyze the effect of transplanting A2 to B donor kidneys on wait time and transplantation rate.
• Analyze outcomes of transplanting Hepatitis C positive donors in hepatitis C negative recipients.
• Discuss lessons learned from transplant centers surveyed under the revised interpretive guidelines.
• Describe basic concepts of regulatory compliance, quality assurance, and performance improvement.

Additional details will be posted as soon as they are available.